Lv41
530 积分 2024-05-02 加入
Ruxolitinib, a novel JAK/STAT-targeted therapy through restoring mucosal homeostasis for chronic rhinosinusitis with nasal polyps
1小时前
已完结
Phenotyping and Endotyping Pediatric Chronic Rhinosinusitis
3个月前
已完结
MicroRNA-21-5p promotes mucosal type 2 inflammation via regulating GLP1R/IL-33 signaling in chronic rhinosinusitis with nasal polyps
4个月前
已完结
Interleukin-33 Promotes Th2/Th17 Response in Eosinophilic and Non-Eosinophilic Nasal Polyps
4个月前
已关闭
Inflammatory Pathways in Residual Asthma Exacerbations Among Mepolizumab-Treated Urban Children
4个月前
已完结
Dupilumab improves sleep quality in chronic rhinosinusitis with nasal polyps
4个月前
已完结
Remission in chronic rhinosinusitis with nasal polyps treated with biologics: a real-life experience
4个月前
已完结
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
4个月前
已完结
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
4个月前
已完结
Inflammatory endotypes of adenoidal hypertrophy based on a cluster analysis of biomarkers
5个月前
已完结
皖公网安备34019202002308
